Healthcare & Medical Investment (TSE:3455) COGS-to-Revenue : 0.34 (As of Jan. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Healthcare & Medical Investment COGS-to-Revenue?

Healthcare & Medical Investment's Cost of Goods Sold for the six months ended in Jan. 2024 was 円832 Mil. Its Revenue for the six months ended in Jan. 2024 was 円2,438 Mil.

Healthcare & Medical Investment's COGS to Revenue for the six months ended in Jan. 2024 was 0.34.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Healthcare & Medical Investment's Gross Margin % for the six months ended in Jan. 2024 was 65.87%.

Healthcare & Medical Investment COGS-to-Revenue Historical Data

The historical data trend for Healthcare & Medical Investment's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healthcare & Medical Investment COGS-to-Revenue Chart

Healthcare & Medical Investment Annual Data

Trend

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

COGS-to-Revenue

Get a 7-Day Free Trial

0.31

0.33

0.32

Healthcare & Medical Investment Semi-Annual Data
	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
COGS-to-Revenue	Get a 7-Day Free Trial													0.34	0.33	0.30	0.34	0.34

Healthcare & Medical Investment COGS-to-Revenue Calculation

Healthcare & Medical Investment's COGS to Revenue for the fiscal year that ended in Jul. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1622.351	/	5070.853
	=	0.32

Healthcare & Medical Investment's COGS to Revenue for the quarter that ended in Jan. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	832.122	/	2438.352
	=	0.34

Healthcare & Medical Investment (TSE:3455) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Healthcare & Medical Investment's Gross Margin % for the six months ended in Jan. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	832.122 / 2438.352
	=	65.87 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Healthcare & Medical Investment COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Healthcare & Medical Investment's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Healthcare & Medical Investment (TSE:3455) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Healthcare & Medical Investment Corp (TSE:3455) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-3, Kanda-ogawamachi, Chiyoda-ku, Tokyo, JPN

Website

http://www.hcm3455.co.jp

Healthcare & Medical Investment Corp is an investment company, which invests in nursing homes facilities and medical related real properties. The company aims to achieve stable earnings from mid- to long-term perspectives through investment in real estate and other related assets. The firm primarily invests in facilities and buildings for the elderly, as well as medical related facilities.

Healthcare & Medical Investment (TSE:3455) Headlines

No Headlines